The metabolic syndrome in pregnancy and its association with child telomere length

Dale McAninch1,2, Tina Bianco-Miotto1,3, Kathy L Gatford1,2

  • 1Robinson Research Institute, University of Adelaide, North Adelaide, SA, 5005, Australia.

Diabetologia
|July 31, 2020
PubMed

Insights

Maternal metabolic syndrome during pregnancy is linked to shorter child telomeres, a sign of accelerated aging. This association was observed at 10 years of age, with no significant differences in child anthropometry or blood pressure.

Area of Science:

  • Reproductive health and child development
  • Genetics and aging biomarkers
  • Metabolic health during pregnancy

Background:

  • The metabolic syndrome, a cluster of conditions increasing heart disease risk, can occur during pregnancy.
  • Telomere length is a biomarker for cellular aging and may be influenced by early-life exposures.
  • Understanding the long-term impact of maternal metabolic health on child development is crucial.

Purpose of the Study:

  • To investigate the association between maternal metabolic syndrome in pregnancy and child telomere length at 10 years of age.
  • To examine the relationship between maternal metabolic syndrome and child anthropometry (weight, BMI) and blood pressure at 10 years.
  • To assess telomere length as a potential biomarker for the effects of pregnancy metabolic health on offspring.

Main Methods:

  • Prospective cohort study (Screening for Pregnancy Endpoints - SCOPE) of nulliparous women.
  • Diagnosis of metabolic syndrome using IDF criteria based on data from 14-16 weeks gestation.
  • Quantitative PCR assessment of telomere length from children's saliva at 10 years of age, with adjustment for confounders.

Main Results:

  • Children born to mothers with metabolic syndrome during pregnancy had 14% shorter telomeres at 10 years of age compared to controls.
  • No significant differences were found in height-for-age, weight-for-age, or BMI z-scores between children based on maternal metabolic syndrome status.
  • Maternal metabolic syndrome in pregnancy was associated with shorter child telomeres, suggesting a potential impact on aging biomarkers.

Conclusions:

  • Maternal metabolic syndrome during pregnancy is associated with shorter telomere length in children at 10 years, indicating accelerated biological aging.
  • The findings highlight the importance of maternal metabolic health for long-term child health outcomes.
  • Further research in larger cohorts is recommended to confirm these associations and explore early-life telomere measurements.
Abstract

Related Concept Videos

Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
67.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.4K
Telomeres and Telomerase02:41

Telomeres and Telomerase

6.6K